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Background:  Anesthesia methods and drugs affect postoperative nausea and vomiting. Propofol is known to 
have antiemetic effects.  We compared the incidence of postoperative vomiting (POV) in children undergoing an 
adenotonsillectomy; anesthesia in one group was induced with propofol and maintained with sevoflurane and 
nitrous oxide, and the other group received total intravenous anesthesia (TIVA) with propofol-remifentanil.
Methods:  Ninety children, ASA physical status I, were assigned randomly to one of two groups.  In the PSN group, 
anesthesia was maintained with 2-3 vol% sevoflurane and 50% nitrous oxide.  In the PR group, anesthesia was 
maintained with 10 mg/kg/h propofol and 0.25 μg/kg/min remifentanil. In both groups, anesthesia was induced 
with 0.5 μg/kg remifentanil and 2 mg/kg propofol.  The incidence of POV and the need for rescue antiemetics were 
assessed in the postanesthesia care unit at 6, 12, and 24 hours postoperatively.
Results:  The total incidence of POV was not significantly different between the groups; POV occurred in eight (17.7%) 
and three (6.7%) children in the PSN and PR groups, respectively.  Postoperative frequency of retching in the recovery 
room was significantly higher in the PSN group, with four children (8.9%) in the PSN group compared to none (0%) in 
the PR group (P = 0.041).  The frequency of POV 24 hrs after exiting the recovery room tended to be higher in the PSN 
group than the PR group, but no statistically significant difference was observed.
Conclusions: If the development of POV in the early anesthetic recovery phase of children undergoing adeno-
tonsillectomy is adequately prevented, propofol-induced anesthesia maintained with sevoflurane-nitrous oxide is as 
safe as TIVA with propofol-remifentanil.  (Korean J Anesthesiol 2010; 59: 185-189)
Key Words:  Adenotonsillectomy, Pediatric, PONV, Sevoflurane, TIVA.
Vomiting after a pediatric adenotonsillectomy: comparison 
between propofol induced sevoflurane-nitrous oxide 
maintained anesthesia and TIVA with propofol-remifentanil
Ji-Hyun Chung
2, Yoon-Hee Kim
1, Young-Kwon Ko
1, Sun-Yeul Lee
1, Yoon-Tae Nam
1, and Seok-Hwa Yoon
1
Department of Anesthesiology and Pain Medicine, 
1Chungnam National University School of Medicine, 
2Eulji University School of 
Medicine, Daejeon, Korea
Received: May 12, 2010.  Revised: May 17, 2010.  Accepted: May 31, 2010.
Corresponding author: Yoon-Hee Kim, M.D., Ph.D., Department of Anesthesiology and Pain Medicine, Chungnam National University School 
of Medicine, Daesa-dong, Jung-gu, Daejeon 301-721, Korea. Tel: 82-42-280-7840, Fax: 82-42-280-7968, E-mail: yhkim0404@cnu.ac.kr
    This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
CC186 www.ekja.org
Vomiting after pediatric adenotonsillectomy Vol. 59, No. 3, September 2010
Introduction 
    The incidence of postoperative vomiting (POV) following a 
pediatric adenotonsillectomy is 40-80%, which is higher than 
strabismus surgery [1].
    Postoperative nausea and vomiting (PONV) is called “the big 
little problem” [2], but severe vomiting is also a major cause of 
pediatric death because it can cause bleeding, dehydration, 
wound dehiscence, and aspiration pneumonia [3]. Even 
mild PONV may result in a delayed hospital discharge with 
increased costs, as well as decreased parental satisfaction and 
an unpleasant experience for the patient [4].
    Anesthetic-related factors that affect the incidence of PONV 
include premedication, intraoperative anesthetic methods and 
drugs, and postoperative factors such as pain management and 
timing of oral food intake [3]. 
    Apfel et al. [5] reported that volatile anesthetics were the 
leading cause of early POV. Compared with isoflurane, total 
intravenous anesthesia (TIVA) with propofol and remifentanil 
resulted in a significantly lower incidence of PONV [6]. 
However, TIVA has some limitations compared with inhalation 
anesthesia in children. Although the same dose of propofol 
is administered to children, a great discrepancy exists in its 
plasma level among individual children [7], and it is also 
difficult to predict the plasma concentration of anesthetic 
agents in a noninvasive manner [8]. There is no optimal dose 
of TIVA agents based on age [8], and the reliability of a BIS 
monitor, which is used to monitor the depth of anesthesia, 
cannot be trusted in children aged 5 years or younger [9]. 
Therefore, it can be inferred that TIVA has a lower degree of 
usefulness than inhalation anesthesia in children undergoing 
surgery in which the incidence of PONV is relatively higher. 
According to Simurina et al. [10] no significant difference was 
observed in the incidence of POV between a group of children 
who underwent an adenotonsillectomy, in which anesthesia 
was induced with propofol-fentanyl and then maintained, and 
that done using sevoflurane. As described here, controversial 
opinions still exist regarding the effects of TIVA for preventing 
PONV in children.
    Although controversial, some studies have reported that the 
incidence of PONV is significantly lower in patients who were 
induced by propofol and then maintained with inhalation 
agents as compared with those who were induced by thiopental 
[11,12]. However, most of these studies were conducted in 
adults.
    Given the above background, we compared the incidence of 
POV in children undergoing an adenotonsillectomy; anesthesia 
in one group was induced with propofol and maintained with 
sevoflurane and nitrous oxide, while the other group was 
induced with propofol-remifentanil and maintained with TIVA. 
Materials and Methods 
    We studied 90 ASA I or II children aged 3-16 years who were 
scheduled for a tonsillectomy with or without an adenoidectomy 
under general anesthesia. The study was approved by the local 
institutional ethics committee, and written informed parental 
consent was obtained. The following cases were excluded from 
the study; patients with central nervous system disorders, those 
with recent or chronic administration of sedative drugs, those 
who had experienced POV, those who had taken an antiemetic 
medication within 24 hours before surgery, and those who had 
a history of motion sickness.
    Patients were fasted after the midnight before surgery. Clear 
liquids were permitted up to 3 hours before surgery. Thirty 
minutes prior to anesthesia induction, all patients were pre-
medicated with midazolam (0.04 mg/kg) and glycopyrrolate 
(0.004 mg/kg) intravenously (IV).
    Upon arrival in the operating room, electrocardiogram, heart 
rate, and oxygen saturation were monitored continuously, and 
non-invasive arterial blood pressure was recorded at 5-minute 
intervals throughout the procedure. Patients were randomly 
selected and then classified into two groups: the PSN group 
in which anesthesia was induced with propofol and then 
maintained with sevoflurane and nitrous oxide (n = 45) and 
the PR group in which TIVA was performed with propofol and 
remifentanil (n = 45). All patients were induced with 2 mg/kg 
propofol IV, following a 20-second administration of 0.5 μg/kg 
remifentanil IV. After intubation, anesthesia was maintained 
with 2-3 vol% sevoflurane and 50% nitrous oxide in oxygen in 
the PSN group, and in the PR group anesthesia was maintained 
with a continuous infusion of 10 mg/kg/h propofol IV, 0.25 μg/
kg/min remifentanil IV, and 50% nitrous oxide in oxygen. During 
surgery, maintenance doses of anesthetics were adjusted to 
maintain blood pressure within ± 20% of baseline in each group. 
In both groups, 0.6 mg/kg rocuronium IV was administered 
to all patients to facilitate endotracheal intubation, and no 
further doses were administered. Controlled ventilation was 
conducted to sustain the end-tidal carbon dioxide between 
35 and 40 mmHg. A tonsillectomy was performed using an 
electrodissection technique, and the adenoidectomy was 
performed using palliative curettage. All patients received 1 
mg/kg ketorolac IV 20 minutes prior to the end of surgery for 
pain control and 10 ml/kg lactated Ringer's solution during the 
operation. At the end of surgery, the neuromuscular blockade 
was reversed by a combination of 0.2 mg/kg pyridostigmine IV 
and 0.008 mg/kg glycopyrrolate IV, and gastric contents were 
suctioned via an orogastric tube before extubation. Patients 
were extubated once end-tidal sevoflurane concentrations 
were less than 0.2% and extubation criteria were met, which 
was defined as a positive head lift, hand grip, and eye-opening 187 www.ekja.org
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following on command. All children were transferred to the 
postanesthesia care unit (PACU). The criteria for discharge from 
the PACU to the ward included stable vital signs, adequate pain 
control, and absence of vomiting for 1 hour.
    In the PACU, and during the first 24 hours after discharge 
from the PACU on the ward, all episodes of emetic symptoms 
(retching, vomiting) were recorded at regular intervals. Vomiting 
was defined as the forceful expulsion of gastric contents from 
the mouth; retching was defined as the labored, spasmodic, 
rhythmic contraction of the respiratory tract muscles, including 
the diaphragm, chest wall, and abdominal wall muscles without 
expulsion of gastric contents. Nausea was not assessed as a 
separate entity in this study considering that the patients were 
young. Retching and vomiting were inclusively defined as POV. 
Data were collected at the PACU and thereafter in the ward at 
4, 12, and 24 hours. Vomiting that occurred more than twice 
was treated with 0.06 mg/kg ondansetron IV. In children who 
complained of severe postoperative pain, 1 mg/kg ketorolac 
sodium was additionally injected IV. The volume of fluid 
therapy was adjusted postoperatively, depending on blood loss, 
POV, and oral intake.
    The statistical analysis was performed using SPSS 11.5. 
Measurements were expressed as mean ± standard deviation 
or percentile values (%). Differences between the groups were 
tested using unpaired Student's t-tests. PONV incidence was 
compared using the chi-square test. P < 0.05 was considered 
statistically significant.
Results
    No statistically significant differences were observed between 
the two groups with respect to age, body weight, body height, 
gender ratio, fluid volume during anesthesia, surgery duration, 
anesthesia, or the number of children who were additionally 
given ketorolac following the surgery. The surgical procedures 
were similar in the two groups (Table 1). 
    The overall incidence of POV was three children (6.7%) in the 
PR group and eight children (17.7%) in the PSN group (P > 0.05). 
More patients in the PSN group (4 children, 8.9%) experienced 
retching than in the PR group (0 children, 0%) in the PACU (P = 
0.041). POV occurred most frequently in the first 6 hours after 
discharge from the PACU (2 cases [4.4%] in the PR group and 7 
cases [15.5%] in the PSN group; Table 2).
    All children were well oxygenated throughout the study 
period, and no airway complications were noted. No patient 
received ondansetron in the PACU or the ward. 
Discussion
    The incidence of POV in the PACU was significantly lower in 
the group that received TIVA with propofol and remifentanil 
compared with those who received sevoflurane and nitrous 
oxide. However, no differences in the incidences of POV were 
found after discharge from the PACU.
    Sevoflurane is a well-tolerated inhalation induction agent 
in all age groups, because it is pleasant smelling and relatively 
non-irritating to the airways [13]. Due to the low blood and 
tissue solubilities and cardiopulmonary stability, it is a suitable 
anesthetic for ambulatory surgery in infants and children [14]. 
The use of sevoflurane for ENT surgery in children has been 
compared with halothane, but PONV is more frequent after 
Table 1. Patient Data
PSN group
(n = 45)
PR group
(n = 45)
Gender (M/F)
Age (years)
Weight (kg)
Height (cm)
Volume of fluids during anesthesia (ml/kg)
Duration of surgery (min)
Duration of anesthesia (min)
Number of patient requiring analgesics 
Surgical procedure
    Tonsillectomy (n)
    Adenotonsillectomy (n)
26/19
7.9 ± 3.2
29.3 ± 12.6
126.8 ± 18.8
10.4 ± 0.8
40.8 ± 13.7
64.9 ± 15.2
1
9
36
27/18
8.0 ± 3.7
33.5 ± 15.9
129.7 ± 21.5
10.6 ± 1.8
39.1 ± 11.5
62.1 ± 12.0
0
5
40
Values are mean ± SD or number. PSN group: anesthesia induction 
with propofoland maintained with sevoflurane/nitrous oxide, PR 
group: total intravenous anesthesia with propofol and remifentanil.
Table 2. Number (%) of Patients Experiencing No Emesis, Retching, 
or Vomiting
PSN group
(n = 45)
PR group
(n = 45)
PACU
    Emesis-free
    Retching
    Vomiting
0-6 hours after discharge from PACU 
    Emesis-free
    Retching
    Vomiting
6-12 hours after discharge from PACU 
    Emesis-free
    Retching
    Vomiting
12-24 hours after discharge from PACU
    Emesis-free
    Retching
    Vomiting
Total
    Overall POV
41 (91)
 4 (8.9)
 2 (4.4)
38
   6 (13.3)
 1 (2.2)
45 (100)
0
0
45 (100)
0
0
   8 (17.7)
45 (100)
  0*
0
43
 2 (4.4)
0
 44 (97.8)
0
 1 (2.2)
45 (100)
0
0
  3 (6.7)
PSN group: anesthesia induction with propofol, maintained with 
sevoflurane/nitrous oxide, PR group: total intravenous anesthesia 
with propofol and remifentanil, PACU: postanesthesia care unit.  *P 
< 0.05 (P = 0.041) versus group PSN.188 www.ekja.org
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halothane anesthesia [15].
    Compared with propofol, sevoflurane shows a similar pattern 
in the maintenance or recovery from anesthesia, or, conversely, 
it may result in a more prompt recovery from anesthesia than 
propofol. However, the incidence of PONV after sevoflurane 
anesthesia is higher than that with propofol [16,17]. According 
to Ved et al. [18] the incidence of POV was relatively lower in the 
first six hours in patients for whom anesthesia was induced with 
propofol compared to halothane, but thereafter no significant 
difference was observed. Also Tramer et al. [19] following a 
meta-analysis of the literature, found that TIVA with propofol, 
rather than inhalation anesthesia, may have a clinically relevant 
effect on PONV but only in the short term. Similarly, according 
to Fredmann et al. [16] the incidence of PONV was lower during 
the first two hours of the early postoperative stage in outpatients 
under general anesthesia with propofol than those for whom 
anesthesia was induced with sevoflurane, and no significant 
difference was observed thereafter. In this study, the incidence 
of PONV was significantly lower only at the PACU in the TIVA 
group, and this agreed with previous reports that TIVA methods 
with propofol reduced the occurrence of nausea and vomiting 
during the early postoperative stage. 
    Propofol prevents PONV by playing a role blocking 5-hydroy-
tryptamine-3 receptors [20] or by directly inhibiting not only 
the chemoreceptor trigger zone in the CNS but also the vagus 
nerve, which is associated with nausea and vomiting [21]. 
But, controversial opinions exist regarding the effects on 
PONV in cases in which propofol was administered to induce 
anesthesia. Chanvej et al. [11] reported that the incidence 
of PONV decreased by 28% in a group in which anesthesia 
was induced with propofol as than when it was induced with 
thiopental sodium in outpatients who underwent laparoscopic 
surgery. Furthermore, Chia et al. [12] reported that propofol 
was effective for preventing PONV when it was used as an 
induction anesthesia agent. According to Grundmann et al. 
[22] no significant difference in the occurrence of PONV was 
observed at a recovery room between a group in which TIVA 
was performed using propofol-remifentanil and that in which 
anesthesia was induced using propofol and then maintained 
using desflurane-nitrous oxide. However, in this study, the 
incidence of retching was significantly higher at the PACU in 
the group that received propofol than in a group in which TIVA 
was performed. These results were in agreement with those 
of Park et al. [23] in patients who underwent laparoscopic 
cholecystectomy, and those of Gan et al. [24].
    In the current study, POV developed intensively during the first 
6 hours following discharge from the PACU in the group that 
was induced with propofol and maintained using sevoflurane-
nitrous oxide. According to Ariffin et al. [25] following 
anesthesia with sevoflurane or halothane in outpatients, 
the incidence of PONV prior to the discharge was relatively 
higher in the sevoflurane group, but it was significantly higher 
following discharge in the halothane group. These authors 
explained that sevoflurane has a faster clearance rate than 
halothane in an in vivo setting. Sevoflurane has a half-life that is 
five times shorter than that of halothane [26]. Accordingly, the 
incidence of vomiting was relatively higher in the PACU, then 
within 2 hours postoperatively, and in most cases, vomiting 
symptoms disappeared within 24 hours [27]. The pattern of 
PONV in the sevoflurane group shown in this study was similar 
to the pharmacokinetic profile of sevoflurane.
    Remifentanil has a context-sensitive half-life of approximately 
3-6 minutes, but it is not subject to the injection time, and 
once injection is stopped, its action promptly disappears. Thus, 
recovery from anesthesia can be predicted [28]. However, the 
incidence of nausea and vomiting appears similar to other 
opioids. In children who underwent a tonsillectomy under 
general anesthesia using sevoflurane or halothane, POV 
occurred at incidences of 10% and 12% in a remifentanil group 
and 10% and 13% in a fentanyl group [29].
    There is also controversy as to the effects of nitrous oxide on 
PONV. According to Splinter and Komocar [30] the incidence 
of POV was relatively higher in children who received dental 
treatments with nitrous oxide than other agents. However, these 
authors noted that there was no effect on the overall incidence 
of POV.
    In the current study, the overall incidence of POV was 17.7% 
in the group in which anesthesia was induced with propofol 
and then maintained with 6.7% sevoflurane-nitrous oxide. This 
might be due not only to propofol/TIVA but also surgical time 
was relatively shorter and other factors such as the effects of mida-
zolam, which was administered prior to anesthesia, and the exclu-
sion of children with a past history of motion sickness or PONV.
    In conclusion, the overall incidence of POV was relatively 
lower in a group in which TIVA was maintained using propofol-
remifentanil rather than a group in which anesthesia was 
induced using propofol and then maintained using sevoflurane-
nitrous oxide. Following a comparison of the time-dependent 
incidence of POV between the two groups, the incidence of POV 
at the PACU was relatively lower in the TIVA group. However, 
during the 24-hr period thereafter, no significant difference was 
observed between the two anesthetic methods. Based on these 
results, it can be inferred that the methods in which anesthesia 
is induced with propofol and maintained with sevoflurane-
nitrous oxide would have a similar profile of safety to those in 
which TIVA is performed using propofol- remifentanil.
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